FC Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Hold
993
0.32% 48
2026
Q1
$913K Sell
993
-44
-4% -$44.6K 0.27% 56
2025
Q4
$1.11M Hold
1,037
0.32% 47
2025
Q3
$791K Hold
1,037
0.23% 63
2025
Q2
$808K Sell
1,037
-30
-3% -$23.3K 0.25% 60
2025
Q1
$881K Sell
1,067
-578
-35% -$481K 0.3% 50
2024
Q4
$1.27M Sell
1,645
-2
-0.1% -$1.66K 0.43% 38
2024
Q3
$1.46M Hold
1,647
0.49% 37
2024
Q2
$1.49M Sell
1,647
-25
-1% -$20K 0.55% 34
2024
Q1
$1.3M Buy
1,672
+7
+0.4% +$4.98K 0.48% 37
2023
Q4
$971K Hold
1,665
0.38% 39
2023
Q3
$895K Hold
1,665
0.38% 41
2023
Q2
$781K Hold
1,665
0.32% 44
2023
Q1
$572K Hold
1,665
0.25% 52
2022
Q4
$609K Hold
1,665
0.29% 46
2022
Q3
$538K Hold
1,665
0.27% 50
2022
Q2
$540K Hold
1,665
0.26% 50
2022
Q1
$477K Hold
1,665
0.21% 45
2021
Q4
$460K Sell
1,665
-14
-0.8% -$3.55K 0.19% 48
2021
Q3
$388K Hold
1,679
0.17% 49
2021
Q2
$385K Hold
1,679
0.17% 51
2021
Q1
$314K Hold
1,679
0.15% 56
2020
Q4
$284K Hold
1,679
0.14% 54
2020
Q3
$249K Hold
1,679
0.14% 50
2020
Q2
$276K Hold
1,679
0.16% 48
2020
Q1
$233K Hold
1,679
0.16% 47
2019
Q4
$222K Buy
+1,679
New +$195K 0.13% 56
2019
Q2
Sell
-1,679
Closed -$218K 54
2019
Q1
$218K Buy
+1,679
New +$204K 0.14% 48

Other funds holding LLY

FC Advisory's LLY Position: Q2 2026 in Review

FC Advisory held its Eli Lilly (LLY) position steady in Q2 2026 at 993 shares worth $1.19M. The position accounts for 0.32% of the portfolio, ranked #48.

FC Advisory first reported a position in LLY in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.49M in Q2 2024. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FC Advisory held 993 shares of Eli Lilly worth $1.19M as of Q2 2026.
  • FC Advisory left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.32% of FC Advisory's portfolio in Q2 2026, its #48 holding.
  • FC Advisory first reported a position in Eli Lilly in Q1 2019 and has held it in 28 quarters since.
  • FC Advisory's Eli Lilly position peaked at $1.49M in Q2 2024.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FC Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.